Graham T Dempsey, PhD, Co-founder and Chief Scientific Officer, Quiver Biosciences will be speaking at the DDW SLAS2025 track – Concept to Cure: Curiosity and Lab Automation in Drug Discovery.

SLAS2025 is on 25-29 January 2025, in San Diego, USA.

Graham Dempsey
Graham Dempsey

This free programme, which will run on 27, 28 and 29 January, will present examples of research and drug development from industry experts using lab automation. Dempsey will be speaking about The Brain Genomic Positioning System (GPS): Navigating to precision CNS therapies through perturbation maps of neuronal function on 28 January.

Dempsey directs the scientific, medical, engineering and AI/ML activities at Quiver, leading the rapid evolution of the company’s foundational technology platforms as well as its small molecule and antisense oligonucleotide therapeutic programs. He holds a B.A. in biochemistry and biophysics from UPenn and a Ph.D. in biophysics from Harvard University.

Speaker line-up:

  • Dr Raminderpal Singh, 20/15 Visioneers 27 January
  • Nicola Richmond, Chief Scientist AI, Recursion 27 January
  • Graham T Dempsey, Quiver Biosciences 28 January
  • Fatah Kashanchi, George Mason University and Heather Branscome, ATCC 28 January
  • Alexander G Godfrey, National Center for Advancing Translational Sciences (NCATS) 28 January
  • Carleen Klumpp-Thomas, National Center for Advancing Translational Sciences (NCATS) 29 January

The track is sponsored by ATCC, Integra Biosciences, Collaborative Drug Discovery (CDD) and Tecan.

Register your interest here.